Publications by authors named "Shelly D Senders"

Claim this Profile
C
Clesrovimab for Prevention of RSV Disease in Healthy Infants.
Heather J Zar, Eric A F Simões, Shabir A Madhi, Octavio Ramilo, Shelly D Senders

N Engl J Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months.
Lars Østergaard, Timo Vesikari, Shelly D Senders, Carl-Erik Flodmark, Pavel Kosina

Vaccine· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of immunogenicity and safety of VARIVAX™ New Seed Process (NSP) in children.
Shelly D Senders, Nickoya D Bundick, Jianing Li, Carol Zecca, Frans A Helmond

Hum Vaccin Immunother· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process.
Gary S Marshall, Shelly D Senders, Julie Shepard, Jerry D Twiggs, Julie Gardner

Hum Vaccin Immunother· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of a cell culture derived trivalent subunit inactivated influenza vaccine administered to healthy children and adolescents: A Phase III, randomized, multicenter, observer-blind study.
Terry Nolan, Tawee Chotpitayasunondh, Maria Rosario Capeding, Simon Carson, Shelly David Senders

Vaccine· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M-M-R(®)II manufactured using recombinant human albumin (rHA) and M-M-R(®)II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children.
Richard T Wiedmann, Keith S Reisinger, Jonathan Hartzel, Edgardo Malacaman, Shelly D Senders

Vaccine· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of age.
David P Greenberg, Corwin A Robertson, Victoria A Landolfi, Amitabha Bhaumik, Shelly D Senders

Pediatr Infect Dis J· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Susan Partridge, Justin Alvey, Henry Bernstein, Mark Blatter, Gerald Bottenfield, Shelly D Senders

Vaccine· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
Terry Nolan, Henry Bernstein, Mark M Blatter, Kenneth Bromberg, Fernando Guerra, Shelly D Senders

Pediatrics· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination.
Michael E Pichichero, Mark M Blatter, Keith S Reisinger, Christopher J Harrison, Candice E Johnson, Shelly D Senders

Pediatr Infect Dis J· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy.
David P Greenberg, Larry K Pickering, Shelly D Senders, Jeffrey D Bissey, Robert A Howard

Pediatrics· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis